Asenapine for schizophrenia
This study is completed in Global. It is testing asenapine for schizophrenia.
In Global
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Global. It is testing asenapine for schizophrenia.
In GlobalThis study is completed. It focuses on schizophrenia and currently lists study information in Japan.
In TokyoThis study is completed. It focuses on bipolarity and currently lists study information in Japan.
Multiple locations, including ChibaThis study is completed. It focuses on schizophrenia and currently lists study information in Japan, South Korea, and Taiwan.
Multiple locations, including SapporoThis study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In AlbuquerqueThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In BelmontThis study has public registry information. It focuses on schizophrenia and currently lists study information in Global.
In GlobalThis study has public registry information. It focuses on depression and currently lists study information in Malaysia.
Multiple locations, including KlangThis study is completed. It focuses on schizophrenia and currently lists study information in France.
In ColombesThis study is completed. It focuses on depression and currently lists study information in India.
In BhubaneswarThis study is completed. It focuses on bipolarity and currently lists study information in France.
In CréteilThis study has public registry information. It focuses on depression and currently lists study information in the United States.
In Belmont